Dr. Devi Prasad Shetty, a renowned Indian cardiac surgeon, has transformed healthcare accessibility through Narayana Health (formerly Narayana Hrudayalaya). Often hailed as the “Henry Ford of heart surgery,” he founded a hospital chain that delivers world-class cardiac care at a fraction of global costs — including thousands of free or heavily subsidized procedures — while generating substantial profits for the organization.
The viral claim that “this Indian makes 400 crore by doing free heart surgeries” stems from popular discussions and case studies highlighting Narayana Health’s innovative approach. While the exact ₹400 crore figure may reference an earlier profit milestone or illustrative example, the core truth remains: the chain sustains a large volume of free/subsidized surgeries through smart economics, not charity alone.
A Revolutionary Model: High Volume, Low Cost, Cross-Subsidization
Dr. Shetty’s vision treats healthcare as a right, not a privilege. He drew inspiration from industrial efficiency, applying assembly-line principles to medicine. Surgeons at Narayana Health perform far more procedures annually than in typical hospitals — often 400–600 heart surgeries per surgeon per year, compared to 100–200 elsewhere. This high throughput slashes per-surgery costs dramatically through economies of scale.
A coronary artery bypass graft (commonly called bypass surgery) at Narayana Health typically costs ₹95,000 to ₹1.2 lakh (roughly $1,100–$1,500 USD), a stark contrast to ₹62 lakh+ in the United States. Over half of patients receive free or subsidized treatment, funded through:
- Philanthropy and charitable contributions.
- Government schemes and micro-insurance programs (like the Yeshasvini cooperative health scheme).
- Cross-subsidization: Wealthier patients (including domestic paying patients and medical tourists) pay higher fees for premium amenities or services, effectively subsidizing care for the underprivileged.
This blended model ensures profitability without compromising quality or access. Outcomes remain excellent, with complication rates comparable to top global institutions.
Scaling Impact and Financial Success
Starting with a flagship facility in Bengaluru, Narayana Health has expanded into a major chain with dozens of hospitals across India and international presence (including the Cayman Islands and a recent entry into the UK via acquisition). The group now offers multi-specialty care beyond cardiology, including oncology, neurosciences, orthopedics, and more.
Financially, the organization has grown robustly. For FY 2024-25 (ending March 2025), consolidated revenue reached approximately ₹5,483 crore (around $670 million USD), with strong EBITDA margins and healthy profit after tax. Recent quarters show continued momentum, including significant revenue boosts from international expansions, though occasional one-time costs (e.g., acquisitions) affect short-term figures. The publicly listed company boasts a market capitalization exceeding ₹35,000 crore in recent periods, reflecting investor confidence in its sustainable model.
Dr. Shetty’s personal net worth, largely tied to his stake in the company, has reached billionaire status (estimated around $2.6 billion in prior reports), underscoring how purpose-driven business can yield both social impact and financial rewards.
A Legacy of Accessible, High-Quality Care
Narayana Health treats millions of patients annually, with a focus on complex, high-acuity cases. Dr. Shetty has personally performed over 100,000 heart operations and continues to advocate for affordable healthcare globally. The chain’s success proves that efficiency, volume, and ethical pricing can coexist with profitability — challenging the notion that quality care must be expensive or exclusive.
In an era of rising healthcare costs, Narayana Health stands as a powerful example of Indian innovation blending compassion with business acumen, saving countless lives while building a thriving enterprise.
About The Author
